Literature DB >> 10361227

Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man.

M Muhaya1, V L Calder, H M Towler, G Jolly, M McLauchlan, S Lightman.   

Abstract

Intermediate uveitis (IU) and Fuchs' heterochromic cyclitis (FHC) are two chronic ocular inflammatory disorders. They differ considerably in ocular morbidity, which is higher in IU. T cell lines were derived from the vitreous humour (VH) and peripheral blood (PB) of 10 patients with IU and four patients with FHC. There was a predominance of CD8+ in all the lines. However, there was a significantly higher percentage of CD4+ T cells in the T cell lines derived from VH of IU (32.0 +/- 8.6%) compared with FHC patients (19. 2 +/- 8.9%) (P = 0.04). The VH-derived T cell lines (VDTC) produced significantly higher levels of IL-2, interferon-gamma (IFN-gamma) and IL-10, but not IL-4, compared with PB-derived T cell lines (PBDTC) in both entities. There was significantly higher IL-2 production by VDTC from IU when compared with FHC patients (1810 +/- 220 pg/ml versus 518 +/- 94 pg/ml; P = 0.009), which could account for the more aggressive clinical features of this condition. In contrast IL-10 production was significantly higher by the VDTC from FHC compared with IU patients. The high IL-10 production by T cells infiltrating VH of FHC patients could down-regulate the inflammatory responses, thereby contributing to the benign clinical course seen in these patients. The accumulation of T cells with differing cytokine profiles in the VH suggests an important role for these cytokines in the pathogenesis of these chronic uveitides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10361227      PMCID: PMC1905319          DOI: 10.1046/j.1365-2249.1999.00921.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Human TH1 and TH2 subsets: doubt no more.

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1991-08

3.  Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes.

Authors:  U Andersson; J Andersson; A Lindfors; K Wagner; G Möller; C H Heusser
Journal:  Eur J Immunol       Date:  1990-07       Impact factor: 5.532

4.  Separation of blood leucocytes, granulocytes and lymphocytes.

Authors:  A Boyum
Journal:  Tissue Antigens       Date:  1974

5.  Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation.

Authors:  H M Towler; P H Whiting; J V Forrester
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

6.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

7.  Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

Authors:  D F Martin; D J Parks; S D Mellow; F L Ferris; R C Walton; N A Remaley; E Y Chew; P Ashton; M D Davis; R B Nussenblatt
Journal:  Arch Ophthalmol       Date:  1994-12

8.  Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production.

Authors:  G Del Prete; M De Carli; F Almerigogna; M G Giudizi; R Biagiotti; S Romagnani
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

9.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

Authors:  F Powrie; M W Leach; S Mauze; S Menon; L B Caddle; R L Coffman
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

10.  Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor.

Authors:  A W Taylor; J W Streilein; S W Cousins
Journal:  Curr Eye Res       Date:  1992-12       Impact factor: 2.424

View more
  21 in total

1.  Protocol for the use of polymerase chain reaction in the detection of intraocular large B-cell lymphoma in ocular samples.

Authors:  Aires Lobo; Narciss Okhravi; Peter Adamson; Brian J Clark; Susan Lightman
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

2.  The effect of pars plana vitrectomy on cystoid macular oedema associated with chronic uveitis: a randomised, controlled pilot study.

Authors:  P Tranos; R Scott; H Zambarakji; H Zambarajki; W Ayliffe; C Pavesio; D G Charteris
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

Review 3.  Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

Authors:  Kenneth G-J Ooi; Grazyna Galatowicz; Virginia L Calder; Susan L Lightman
Journal:  Clin Med Res       Date:  2006-12

Review 4.  Role of dendritic cell subsets in immunity and their contribution to noninfectious uveitis.

Authors:  Ping Chen; Alastair K Denniston; Sima Hirani; Susan Hannes; Robert B Nussenblatt
Journal:  Surv Ophthalmol       Date:  2015-01-28       Impact factor: 6.048

5.  Intracellular T lymphocyte cytokine profiles in the aqueous humour of patients with uveitis and correlation with clinical phenotype.

Authors:  T Hill; G Galatowicz; T Akerele; C H Lau; V Calder; S Lightman
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

6.  Fuchs' heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis?

Authors:  Akesbi Jad; Terrada Céline; Bodaghi Bahram; LeHoang Phuc; Cassoux Nathalie
Journal:  Int Ophthalmol       Date:  2012-10-16       Impact factor: 2.031

7.  Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitis.

Authors:  P Trittibach; S E Barker; C A Broderick; M Natkunarajah; Y Duran; S J Robbie; J W B Bainbridge; A J Smith; G-M Sarra; A D Dick; R R Ali
Journal:  Gene Ther       Date:  2008-06-26       Impact factor: 5.250

Review 8.  Ocular complications of childhood rheumatic diseases: uveitis.

Authors:  Andreas Reiff
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.686

9.  High dose infliximab in the treatment of refractory uveitis: does dose matter?

Authors:  Sukesh Sukumaran; Katherine Marzan; Bracha Shaham; Andreas Reiff
Journal:  ISRN Rheumatol       Date:  2012-01-05

10.  Th1- and Th2-related chemokine and chemokine receptor expression on the ocular surface in endotoxin-induced uveitis.

Authors:  Liem Trinh; Françoise Brignole-Baudouin; Aude Pauly; Hong Liang; Marianne Houssier; Christophe Baudouin
Journal:  Mol Vis       Date:  2008-12-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.